You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
The caveat is that the transcriptome of cancer cells could be dominated by genomic aberrations. As seen in so many single-cell cancer cell UMAPs, cancer cells are clustered by patients. For the immune/stroma population, the risk is low.
But since CellTrek used the co-embedding strategy, there is a chance that it can remove the patient-specific effect. It is always to side-by-side check the co-embedding UMAP colored by 1) st/sc and 2) cell state/cell type. In this way, you would know if the single tumor cells find some matched spots on ST. Additionally, check the genes.
If there is a lack of single-cell transcriptome data from the same patient, can we use single-cell transcriptome data from multiple patients
with the same type of cancer for celltrek analysis?
The text was updated successfully, but these errors were encountered: